GENinCode (LON:GENI) Reaches New 1-Year Low – Time to Sell?

Shares of GENinCode Plc (LON:GENIGet Free Report) hit a new 52-week low during trading on Thursday . The company traded as low as GBX 3 ($0.04) and last traded at GBX 3.10 ($0.04), with a volume of 629877 shares traded. The stock had previously closed at GBX 3.15 ($0.04).

GENinCode Trading Down 1.6 %

The company has a market capitalization of £5.32 million, a price-to-earnings ratio of -0.87 and a beta of 0.66. The business has a fifty day moving average price of GBX 3.68 and a 200 day moving average price of GBX 4.35. The company has a debt-to-equity ratio of 9.28, a current ratio of 2.60 and a quick ratio of 15.89.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

See Also

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.